Active pharmaceutical ingredient (API) manufacturers, excipient suppliers, and Contract Development and Manufacturing Organizations (CDMOs) play a central role in enabling pharmaceutical development and commercialization. They provide critical inputs, formulation expertise, and manufacturing capabilities across small molecules, biologics, and advanced therapies. The segment faces growing complexity driven by stringent regulatory requirements, high quality standards, and increasing supply chain vulnerabilities, particularly around the sourcing and qualification of APIs and excipients. Companies must manage global variations in Good Manufacturing Practice (GMP) standards, supplier dependencies, and geopolitical factors such as trade restrictions and localization policies, all of which impact sourcing strategies, production planning, and market access. Rising expectations from sponsors around speed, flexibility, and reliability are pushing CDMOs to expand capacity and offer integrated, end-to-end services. At the same time, innovation in process development, advanced modalities such as cell and gene therapies, and personalized medicines requires continuous investment in capabilities, technologies, and expertise to remain competitive.

We support CDMOs and API and ingredient manufacturers across the full spectrum of strategic and operational capabilities. 

  • Corporate Strategy: we define global ambitions, assess market opportunities across APIs, excipients, and manufacturing services, optimize product and service portfolios, design scalable business models, and develop multi-year growth plans, including capacity expansion, geographic footprint, and strategic partnerships across the pharma value chain
  • Customer Insights: we map key stakeholders – including sponsors, procurement teams, regulatory authorities, and internal manufacturing functions – capture the voice of clients, and refine value propositions to strengthen long-term relationships, reliability, and differentiation
  • Commercial Strategy: we advise on go-to-market models, key account strategies, service launch readiness, commercial excellence initiatives, pricing and contracting frameworks (including long-term supply agreements), competitive benchmarking, and differentiation in highly competitive and price-sensitive markets
  • M&A and Transactions: we conduct commercial and vendor due diligence, build-up strategies, acquisitions, and post-merger integration to expand capabilities and scale operations
  • Organization and Transformation: we design governance models, target operating structures, and PMO frameworks to enhance operational efficiency, cross-functional alignment (R&D, manufacturing, quality), and risk mitigation across global operations
  • Manufacturing Strategy: we advise on make-or-buy decisions, outsourcing strategies, capacity planning, network optimization, and cost/margin improvement, with a focus on quality, regulatory compliance, and supply chain resilience

By combining deep sector expertise with end-to-end strategic and operational support, we help CDMOs and raw material manufacturers enhance operational excellence, differentiate their service offerings, navigate regulatory and geopolitical complexity, strengthen client partnerships, and drive sustainable growth across global markets.